Skip to main content
Skip to header right navigation
Skip to site footer
Endogenex
Bringing New Energy to the Treatment of Type 2 Diabetes
Menu
ReCET
Patients
Clinical Providers
About Us
News
Contact
Clinical Studies
Uncategorized
Stacey Pugh Combines Bedside Background with Market Experience to Affect Change for Type 2 Diabetes
Endogenex™ Appoints Christopher Sorli as Chief Medical Officer
Endogenex™ Appoints Medical Device Executive, Stacey Pugh, Chief Executive Officer
7News Australia report: Clinical study evaluating technology to treat Type 2 Diabetes being expanded
Clinical study participant with Type 2 Diabetes shares his story
CBS Minnesota report: Mayo Clinic participates in study to evaluate novel Type 2 Diabetes treatment
